Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-320-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.17.2-320-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, the Protocol to the Euro-Mediterranean Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA) between Member States of the European Union and Israel will facilitate trade through a unified regulatory framework, especially in the field of drugs and pharmaceuticals and in particular generics. I am convinced that, from an economic and technical standpoint, this protocol to an existing agreement, especially in a time of economic crisis, is a beneficial step forward not only for industry, but in particular for the end user, the European patient.
Israel is an important democratic partner for the EU in the Middle East and the progress in mutual relations is demonstrated by 60 new joint projects in 15 different areas adopted recently in the EU-Israel Association Council. I unequivocally support the adoption of this agreement, as rejection of it would certainly not represent a constructive stance or contribute to an improvement in Israeli-Palestinian relations."@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples